Canadian Investment Regulatory Organization Trading Halt - APC.H

Stockhouse Dec 5, 2023 20:50

Advanced Proteome Therapeutics to Proceed With Its Proposed Plan of Arrangement

Burnaby, British Columbia--(Newsfile Corp. - March 6, 2023) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) ("APC" or the "Company") is pleased to announce that all conditions hav

newsfileMar 7, 2023 07:50

Advanced Proteome Therapeutics Announces Appointment of Mr. Cory Brandolini to the Board of Directors

Vancouver, British Columbia--(Newsfile Corp. - November 21, 2022) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E8) ("APC" or the "Company") is pleased to announce that it has appoi

newsfileNov 22, 2022 08:45

Advanced Proteome Therapeutics Receives Notice of Allowance for Patent Claims

Vancouver, British Columbia--(Newsfile Corp. - April 13, 2022) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E8) ("APC" or the "Company") is pleased to announce that its US subsidia

newsfileApr 13, 2022 22:36

Advanced Proteome Therapeutics Announces Warrant Extension

Vancouver, British Columbia--(Newsfile Corp. - March 18, 2022) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) ("APC" or the "Company") announces that, it has applied to the TSX V

newsfileMar 19, 2022 03:56

Advanced Proteome Therapeutics Update on Plans for 2022

Vancouver, British Columbia--(Newsfile Corp. - February 3, 2022) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) ("APC" or the "Company"), is pleased to announce that its US subsi

Newsfile Corp.Feb 4, 2022 04:00